155 related articles for article (PubMed ID: 11344738)
1. Herceptin-taxol related hand and foot syndrome.
Merimsky O; Inbar MJ
Isr Med Assoc J; 2000 Oct; 2(10):786. PubMed ID: 11344738
[No Abstract] [Full Text] [Related]
2. Hand-foot syndrome in breast cancer patients receiving adjuvant chemotherapy.
Lee CK; Lynch J
Intern Med J; 2007 Apr; 37(4):281-2. PubMed ID: 17388876
[No Abstract] [Full Text] [Related]
3. Diagnosis in oncology. Hand-foot syndrome.
Jucgla A; Sais G
J Clin Oncol; 1997 Sep; 15(9):3164. PubMed ID: 9312563
[No Abstract] [Full Text] [Related]
4. Trastuzumab-related palmar plantar erythrodysaesthesia.
Tho LM; Bose N; Robertson L; Bhattacharya S; McClue L; Anderson L; Fraser E; Graham K; Yosef H; Lumsden G
Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):80-1. PubMed ID: 22019483
[No Abstract] [Full Text] [Related]
5. Images in clinical medicine. Chemotherapy-induced acral erythema.
Pirisi M; Soardo G
N Engl J Med; 1994 May; 330(18):1279. PubMed ID: 8145783
[No Abstract] [Full Text] [Related]
6. Acute and painful erythema of the hands and feet. Acral erythema induced by chemotherapy.
Revenga Arranz F; Fernández-Durán DA; Grande C; Rodríguez Peralto JL; Vanaclocha Sebastián F
Arch Dermatol; 1997 Apr; 133(4):499-500, 502-3. PubMed ID: 9126025
[No Abstract] [Full Text] [Related]
7. [Effect of Herceptin combined with Taxol on patients with Her-2/neu overexpressing metastatic breast cancer].
Luo RC; Li AM; Zhang JY; Liao WJ; Ji CY; Miao JX
Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):52-4. PubMed ID: 15059359
[TBL] [Abstract][Full Text] [Related]
8. Hand-foot syndrome.
Pike K
Oncol Nurs Forum; 2001; 28(10):1519-20. PubMed ID: 11759299
[No Abstract] [Full Text] [Related]
9. Bevacizumab-induced hand-foot syndrome: circumscribed type.
Munehiro A; Yoneda K; Nakai K; Demitsu T; Moriue T; Moriue J; Yokoi I; Fujita N; Matsuura N; Ishikawa S; Yokomise H; Kubota Y
Br J Dermatol; 2010 Jun; 162(6):1411-3. PubMed ID: 20184580
[No Abstract] [Full Text] [Related]
10. Acral lentiginosis associated with tegafur/gimeracil/oteracil (TS-1).
Park YJ; Soh BW; Lee ES
Eur J Dermatol; 2017 Apr; 27(2):209-210. PubMed ID: 28251899
[No Abstract] [Full Text] [Related]
11. [Intestinal perforation: an unusual adverse event of bevacizumab and paclitaxel combined therapy for a metastatic breast cancer].
Mychaluk J; Piprot C; Sevestre H; Merviel P; Gondry J; Fauvet R
Presse Med; 2009 Sep; 38(9):1370-4. PubMed ID: 19349140
[No Abstract] [Full Text] [Related]
12. Paclitaxel-induced neutrophilic adverse reaction and acral erythema.
Cruz A; Temu T; Hines-Telang G; Kroumpouzos G
Acta Derm Venereol; 2011 Jan; 91(1):86-7. PubMed ID: 21031283
[No Abstract] [Full Text] [Related]
13. Taxol-induced acral erythema.
de Argila D; Dominguez JD; Iglesias L
Dermatology; 1996; 192(4):377-8. PubMed ID: 8864381
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced palmer planter erythrodysesthesia.
Bhasin S; Sunita ; Gupta DK; Kataria SP; Saluja S; Sharma M
J Assoc Physicians India; 2005 Feb; 53():155-6. PubMed ID: 15847041
[TBL] [Abstract][Full Text] [Related]
15. [Blisters unlike others].
Gugerli O; Leupin N
Rev Med Suisse; 2006 Apr; 2(62):1076-7. PubMed ID: 16711153
[No Abstract] [Full Text] [Related]
16. Palisaded neutrophilic and granulomatous dermatitis in a rheumatoid arthritis patient after treatment with adalimumab.
Umezawa Y; Ito K; Nakagawa H
Eur J Dermatol; 2013; 23(6):910-1. PubMed ID: 24201093
[No Abstract] [Full Text] [Related]
17. Sunitinib-induced hand-foot syndrome: a new, distinct form.
Fife DJ; Wu JJ; Behnam SE; Linden KG
Clin Exp Dermatol; 2010 Mar; 35(2):200-1. PubMed ID: 19486049
[No Abstract] [Full Text] [Related]
18. Three cases of chemotherapy-induced acral erythema.
Komamura H; Higashiyama M; Hashimoto K; Takeda K; Kimura H; Tani Y; Ogawa H; Yoshikawa K
J Dermatol; 1995 Feb; 22(2):116-21. PubMed ID: 7722086
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous photosensitivity induced by paclitaxel and trastuzumab therapy associated with aberrations in the biosynthesis of porphyrins.
Cohen AD; Mermershtain W; Geffen DB; Schoenfeld N; Mamet R; Cagnano E; Cohen Y; Halevy S
J Dermatolog Treat; 2005 Feb; 16(1):19-21. PubMed ID: 15897162
[TBL] [Abstract][Full Text] [Related]
20. Palmar-plantar erythrodysaesthesia and non-pegylated liposomal doxorubicin. A case study.
Tamayo-Orbegozo E; Iruin-Sanz A; Oñate-Muzás E; Segrelles-Bellmunt G
Farm Hosp; 2011; 35(1):46-7. PubMed ID: 20619714
[No Abstract] [Full Text] [Related]
[Next] [New Search]
